140 related articles for article (PubMed ID: 2444845)
21. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
[TBL] [Abstract][Full Text] [Related]
22. No inflammation? No cancer! Clear HBV early and live happily.
Villa E; Fattovich G
J Hepatol; 2010 May; 52(5):768-70. PubMed ID: 20356646
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
Chang MH
Clin Liver Dis; 2010 Aug; 14(3):521-30. PubMed ID: 20638029
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis B virus infection in Tonga: identifying high risk groups for immunization with hepatitis B vaccine.
Wainwright RB; McMahon BJ; Bender TR; Heyward WL; Nakanishi S; Wainwright KY; Foliaki S; Erickson SL; Fields HA
Int J Epidemiol; 1986 Dec; 15(4):567-71. PubMed ID: 2950066
[TBL] [Abstract][Full Text] [Related]
25. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.
Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D
Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
28. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Mok TS; Yeo W; Yu S; Lai P; Chan HL; Chan AT; Lau JW; Wong H; Leung N; Hui EP; Sung J; Koh J; Mo F; Zee B; Johnson PJ
J Clin Oncol; 2005 Nov; 23(31):8041-7. PubMed ID: 16258102
[TBL] [Abstract][Full Text] [Related]
29. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
30. Control of hepatitis B virus among Alaskan natives.
Kane MA
Hepatology; 1988; 8(4):976-7. PubMed ID: 2968947
[No Abstract] [Full Text] [Related]
31. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC
Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.
Gilson RJ; de Ruiter A; Waite J; Ross E; Loveday C; Howell DR; Tedder RS; Weller IV
Sex Transm Infect; 1998 Apr; 74(2):110-5. PubMed ID: 9634322
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
[TBL] [Abstract][Full Text] [Related]
35. Primary prevention of hepatocellular carcinoma in developing countries.
Wild CP; Hall AJ
Mutat Res; 2000 Apr; 462(2-3):381-93. PubMed ID: 10767647
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B vaccines: protective efficacy and therapeutic potential.
Michel ML; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
[TBL] [Abstract][Full Text] [Related]
37. Primary and secondary prevention of liver cancer caused by HBV.
Blumberg BS
Front Biosci (Schol Ed); 2010 Jan; 2(2):756-63. PubMed ID: 20036981
[TBL] [Abstract][Full Text] [Related]
38. Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Akuta N; Suzuki F; Kobayashi M; Hara T; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
J Med Virol; 2014 Jan; 86(1):131-8. PubMed ID: 24123090
[TBL] [Abstract][Full Text] [Related]
39. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus infection, its sequelae, and prevention by vaccination.
Huang LM; Lu CY; Chen DS
Curr Opin Immunol; 2011 Apr; 23(2):237-43. PubMed ID: 21257300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
